Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Desmoid Tumors × nirogacestat × Clear all

Phase

Phase 2 4 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Desmoid Tumors 1

Interventions

nirogacestat 1 Sorafenib 1 Saline Solution 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03785964 2025-01-31

DeFi

SpringWorks Therapeutics, Inc.

Phase 3 Completed

142 enrolled 21 charts 1 FDA

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡